Bio-gate AG
Bio-Gate AG provides technologies and customized solutions for health and hygiene in Germany. The company offers HyProtect, a plasma coating which protects the surfaces of medical implants against bacterial colonization; and MicroSilver BG, an elemental microporous silver additive. It distributes its products to veterinarians and veterinary clinics. The company was incorporated in 2005 and is bas… Read more
Bio-gate AG (BIG1) - Total Liabilities
Latest total liabilities as of December 2024: €2.16 Million EUR
Based on the latest financial reports, Bio-gate AG (BIG1) has total liabilities worth €2.16 Million EUR as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Bio-gate AG - Total Liabilities Trend (2020–2024)
This chart illustrates how Bio-gate AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Bio-gate AG Competitors by Total Liabilities
The table below lists competitors of Bio-gate AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Melkior Resources Inc
PINK:MKRIF
|
USA | $235.55K |
|
MICube Solution Inc
KQ:373170
|
Korea | ₩6.90 Billion |
|
Prima Cakrawala Abadi PT
JK:PCAR
|
Indonesia | Rp22.92 Billion |
|
ALNYLAM PHARMA
MU:DUL
|
Germany | €4.17 Billion |
|
ATI Airtest Technologies Inc
PINK:AATGF
|
USA | $5.37 Million |
|
Chitose Internasional Tbk
JK:CINT
|
Indonesia | Rp165.91 Billion |
|
Fly-E Group, Inc. Common Stock
NASDAQ:FLYE
|
USA | $18.79 Million |
|
Trutankless Inc
PINK:TKLS
|
USA | $7.73 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down Bio-gate AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.13 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.23 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.55 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bio-gate AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bio-gate AG (2020–2024)
The table below shows the annual total liabilities of Bio-gate AG from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €2.16 Million | +19.42% |
| 2023-12-31 | €1.81 Million | -8.07% |
| 2022-12-31 | €1.97 Million | +36.40% |
| 2021-12-31 | €1.44 Million | -18.06% |
| 2020-12-31 | €1.76 Million | -- |